Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

FUW-ubiquitin-EphB3-SV40-GFP (B3G) Citations (2)

Originally described in: EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells.
Cortina C, Palomo-Ponce S, Iglesias M, Fernandez-Masip JL, Vivancos A, Whissell G, Huma M, Peiro N, Gallego L, Jonkheer S, Davy A, Lloreta J, Sancho E, Batlle E Nat Genet. 2007 Nov;39(11):1376-83. Epub 2007 Sep 30.
PubMed Journal

Articles Citing FUW-ubiquitin-EphB3-SV40-GFP (B3G)

Articles
Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer. Xu TP, Wang WY, Ma P, Shuai Y, Zhao K, Wang YF, Li W, Xia R, Chen WM, Zhang EB, Shu YQ. Oncogene. 2018 Sep;37(36):5020-5036. doi: 10.1038/s41388-018-0308-y. Epub 2018 May 23. PubMed
EZH2-mediated epigenetic suppression of EphB3 inhibits gastric cancer proliferation and metastasis by affecting E-cadherin and vimentin expression. Zhao K, He J, Wang YF, Jin SD, Fan Y, Fang N, Qian J, Xu TP, Guo RH. Gene. 2019 Feb 20;686:118-124. doi: 10.1016/j.gene.2018.11.015. Epub 2018 Nov 6. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.